A Multicenter Analysis of Elvitegravir Use During Pregnancy on HIV Viral Suppression and Perinatal Outcomes

Martina L. Badell,Anandi N. Sheth,Florence Momplaisir,Lisa Rahangdale,Jo Nell E. Potter,Padmashree C. Woodham,Gweneth B. Lazenby,William R. Short,Scott Gillespie,Nevert Baldreldin,Emily S. Miller,Gregg Alleyne,Lunthita Duthely,Stephanie M. Allen,Judy Levison,Rana Chakraborty

A Multicenter Analysis of Elvitegravir Use During Pregnancy on HIV Viral Suppression and Perinatal Outcomes

2019

Martina L. Badell
Anandi N. Sheth
Florence Momplaisir
Lisa Rahangdale
Jo Nell E. Potter
Padmashree C. Woodham
Gweneth B. Lazenby
William R. Short
Scott Gillespie
Nevert Baldreldin
Emily S. Miller
Gregg Alleyne
Lunthita Duthely
Stephanie M. Allen
Judy Levison
Rana Chakraborty

Background There is a knowledge gap on the clinical use of elvitegravir (EVG) during pregnancy and maternal viral suppression. Our objective was to evaluate the effects of EVG use in pregnancy on rates of HIV virologic suppression and perinatal outcomes.

Keywords:

Intensive care medicine
Elvitegravir
Pregnancy
Medicine
human immunodeficiency virus
Obstetrics and gynaecology
Gestational age
Premature birth
viral suppression
Obstetrics
transmission rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations